The role of pharmacogenetics in personalizing anticoagulant therapy: data from the Astrakhan region
The metabolic characteristics of anticoagulants largely depend on the patient’s genetic profile, determining the variability of pharmacological response to drugs and the risk of adverse reactions. Among the key genes encoding enzymes responsible for anticoagulant metabolism are CES1, CYP2C9, and VKO...
Guardado en:
| Autores principales: | , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Russo |
| Publicado: |
Volgograd State Medical University, Pyatigorsk Medical and Pharmaceutical Institute
2026-07-01
|
| Colección: | Фармация и фармакология (Пятигорск) |
| Materias: | |
| Acceso en línea: | https://www.pharmpharm.ru/jour/article/view/1927 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|